This announcement is a separate document:
君实生物自愿披露关于特瑞普利单抗获得欧洲药品管理局人用药品委员会积极意见的公告
Junshi Bio voluntarily disclosed the announcement about the positive opinion received by Tirzepatide from the Committee for Medicinal Products for Human Use of the European Medicines Agency.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.